Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Industry Questions On CDRH Reform Plans Hold Up User Fee Progress

This article was originally published in The Gray Sheet

Executive Summary

Device industry representatives are demanding that FDA release more details about what resources will be required to support planned regulatory reforms before they will map out a final user fee reauthorization agreement.

You may also be interested in...



FDA Wary Of Industry’s New Pre-Market Review Goal Proposals

Recent device industry proposals for more aggressive pre-market review goals could result in fewer device clearances and approvals, FDA warns.

FDA Wary Of Industry’s New Pre-Market Review Goal Proposals

Recent device industry proposals for more aggressive pre-market review goals could result in fewer device clearances and approvals, FDA warns.

Creeping Toward Compromise: Draft Device User Fee Pact Possible This Month

Despite several holdups in user fee negotiations, progress appears to be picking up and FDA hopes to reach a draft agreement with industry by the end of August.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT030369

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel